Bevacizumab in the treatment of patients with advanced breast cancer: where have we landed?

Por Dirix, L. Y., Van Dam, P. A., Prove, A. M., Vermeulen, P. B.
Publicado em 2010

Immunohistochemical study of topoisomerase II-alpha expression in primary ductal carcinoma of the breast.

Por Hellemans, P, van Dam, P A, Geyskens, M, van Oosterom, A T, Buytaert, P, Van Marck, E
Publicado em 1995

Prognostic value of bcl-2 expression in invasive breast cancer.

Por Hellemans, P., van Dam, P. A., Weyler, J., van Oosterom, A. T., Buytaert, P., Van Marck, E.
Publicado em 1995

The socio-economical impact of intravenous (IV) versus subcutaneous (SC) administration of trastuzumab: future prospectives

Por Papadmitriou, K., Trinh, X.B., Altintas, S., Van Dam, P.A., Huizing, M.T., Tjalma, W.A.A.
Publicado no Facts Views Vis Obgyn (2015)

Tissue preparation for simultaneous flow cytometric quantitation of tumour associated antigens and DNA in solid tumours.

Por van Dam, P A, Watson, J V, Lowe, D G, Cox, H, Curling, M, Shepherd, J H
Publicado em 1990

Prognostic value of prostaglandin F2 alpha concentrations in breast carcinoma.

Por van Dam, P A, Vergote, I B, Laekeman, G M, Keersmaeckers, G H, Uyttenbroeck, F L, Herman, A G
Publicado em 1989

Benchmarking and audit of breast units improves quality of care

Por van Dam, P.A., Verkinderen, L., Hauspy, J., Vermeulen, P., Dirix, L., Huizing, M., Altintas, S., Papadimitriou, K., Peeters, M., Tjalma, W.
Publicado em 2013

Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma.

Por van Dam, P A, Vergote, I B, Lowe, D G, Watson, J V, van Damme, P, van der Auwera, J C, Shepherd, J H
Publicado em 1994

A cross-sectional, multicentre, epidemiological study on human papillomavirus (HPV) type distribution in adult women diagnosed with invasive cervical cancer in Belgium

Por Tjalma, W.A.A., Trinh, X.B., Rosenlund, M., Makar, A.P., Kridelka, F., Rosillon, D., Van Dam, P.A., Collas De Souza, S., Holl, K., Simon, P., Jenkins, D.
Publicado no Facts Views Vis Obgyn (2015)

The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer

Por Trinh, X B, Tjalma, W A A, Vermeulen, P B, Van den Eynden, G, Van der Auwera, I, Van Laere, S J, Helleman, J, Berns, E M J J, Dirix, L Y, van Dam, P A
Publicado em 2009

Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer

Por Peeters, D J E, Van den Eynden, G G, van Dam, P-J, Prové, A, Benoy, I H, van Dam, P A, Vermeulen, P B, Pauwels, P, Peeters, M, Van Laere, S J, Dirix, L Y
Publicado em 2011

Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes

Por Peeters, D J E, van Dam, P-J, Van den Eynden, G G M, Rutten, A, Wuyts, H, Pouillon, L, Peeters, M, Pauwels, P, Van Laere, S J, van Dam, P A, Vermeulen, P B, Dirix, L Y
Publicado em 2014

Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype

Por Van der Auwera, I, Van Laere, S J, Van den Bosch, S M, Van den Eynden, G G, Trinh, B X, van Dam, P A, Colpaert, C G, van Engeland, M, Van Marck, E A, Vermeulen, P B, Dirix, L Y
Publicado em 2008

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting

Por Peeters, D J E, De Laere, B, Van den Eynden, G G, Van Laere, S J, Rothé, F, Ignatiadis, M, Sieuwerts, A M, Lambrechts, D, Rutten, A, van Dam, P A, Pauwels, P, Peeters, M, Vermeulen, P B, Dirix, L Y
Publicado em 2013